ERBB2 and congestive heart failure: Cardiotoxicity is a common toxicity of anti-HER2 drugs, which is usually manifested as a decrease in left ventricular ejection fraction (LVEF) and occasionally as congestive heart failure (CHF) (Pondé et al., 2016).